Breast Lesion Localization Methods Market size to exceed US $1,980 Mn by 2026

June 27, 2019

Worldwide breast lesion localization methods market is expected to surpass $1,980 million by 2026, according to the latest research available at Market Study Report LLC, report provides detailed segmentation of the breast lesion localization methods market based on type, technology and region.

For the uninitiated, breast lesions are uncommon alterations in the breast tissue due to injuries or disorders. There are two types of breast lesions, the benign lesion is non-cancerous whereas the malignant lesion is cancerous. Breast tumors are a common concern among women of all ages. The condition can change the shape of the breast and cause immense pain.

More than 90% lumps are benign cancer, however, 10% do result in malignant cancer. Breast cancer can be diagnosed through triple test comprising breast imaging, physical analysis, and biopsy. If the outcomes of the diagnosis suggest the tumor is malignant then the patient will require a lesion surgery, which will need lesion localization devices. Choosing the right localization method depends on a number of factors including mean localization time, effectiveness, ease of use, surgery cost, safety, patient age, and others.

According to the report, the worldwide breast lesion localization methods market is mostly driven by the high occurrence rate of breast cancer. Data by the World Cancer Research Fund International suggests that around 1.7 million cases of breast cancer were recorded worldwide, in 2012. The highest incidence of breast cancer was recorded in North America. The occurrence of breast cancer in the region was roughly 80 per 100,000 people in Canada.

Upturn in the number of breast cancer cases has overtly increased the awareness about the disease among women, increasing the demand for effective treatment which will eventually stimulate breast lesion localization methods market growth. Early diagnosis of the malignancy of non-palpable and palpable breast lesions can also lead to operative and timely treatment of several breast disorders further impelling the market.

The report offers a detailed analysis of the breast lesion localization methods market growth stimulators, opportunities, and restraints during the projected timeline. In addition, a comprehensive analysis of the industry with respect to competitive landscape, regional contribution, and type is also included.

Request sample copy of this Report@

In terms of type, the global breast lesion localization methods market is categorized into Radioisotope Localization Magnetic Tracer, Wire Localization Biopsy, and Others. The radioisotope localization segment is further divided into Radioactive seed localization and Radio-guided occult lesion localization. Based on the findings of the report, wire localization is estimated to dominate the market owed to its early advancement and higher implementation across oncology treatment centers and hospitals.

The report anticipates magnetic tracers to be the fastest growing segment during the foreseeable timeline owing to its improved efficiency for the introduction of novel mechanisms for cancer cure. The perfect example for the same is the combination of magnetic tracer and Sentimag probe as Sienna+ forming a precise & nontoxic method. The segment is further supported by factors like cost-effectiveness, premium quality surgical design, and enhanced workflow management, cites the report.

The competitive landscape of the global breast lesion localization methods market includes eminent industry players such as Cianna Medical, STERYLAB, Cook Medical, CP Medical, Inc., Argon Medical Devices, Inc., SOMATEX Medical Technologies GmbH, and C.R. BARD, Inc. among others. Profiles of these companies have been highlighted in the report under business overview, product benchmarking, financials, and recent developments. These companies are employing tactics such as launching new products in an effort to meet patient demand and to enhance their position in the business space.